Intelligent Omics Ltd

Intelligent OMICS (Intellomx) have developed a suite of AI and machine learning driven approaches designed to reveal fundamental biological drivers of disease. Using algorithmic neural network techniques and network inference approaches Intellomx interrogates OMICS data sets to identify robust molecular characteristics of disease, determine how those molecular features influence disease and where they sit in recognised pathways. This intelligence can then be used to validate hypotheses, identify new drug targets or determine molecular signatures for diagnostic purposes.

Digital Twins, IoT, Artificial Intelligence and Industry 4.0 consultants